A 19-year-old Richmond man attending his mother's drug trial this week was arrested in an unrelated theft case after officers recognized him in the courtroom. Full story
Patients implanted with a mechanical heart-assistance device made by HeartWare International Inc have an unexpectedly high 9.2 percent chance of developing a potentially life-threatening blood clot per year, newly-released data shows. Full story
Nov. 19: Health and Human Services Secretary Kathleen Sebelius is telling American women and insurance companies to keep doing what they’ve been doing about breast cancer screening. Dr. Nancy Snyderman talks with a panel of experts.
Nov. 2: Patients who participate in clinical trials aren’t always notified if the medical device or drug being tested fails. How can participants in trials protect themselves? Dr. Nancy Snyderman talks with a panel of experts.
Nov. 2: From prescriptions to clinical trials and insurance, Dr. Billy Goldberg, author of “Why Do Men Have Nipples,” fills you in on the things your doctor isn’t telling you.
Oct. 25: NBC’s Lester Holt speaks with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease.
Oct. 19: More parents of children who are short but otherwise healthy are turning to human growth hormone to give their children a leg up, literally. Dr. Nancy Snyderman talks with a panel of experts about where to draw the line on medical solutions for being short.
Registered Nurse Ruthann Schrock administers a standard flu vaccine to Will Ross, 16, of Iowa City, Iowa during the start of a clinical trial on when the H1N1 flu shot should be given with the seasonal shot to make it most effective Monday, Aug. 31, 2009 at the University of Iowa Children's Hospital
Geoffrey von Maltzahn has figured out ways to use tiny particles of gold to seek out and destroy cancer cells without side effects such as hair loss and nausea associated with chemotherapies. Gold nanorods rods are injected into the bloodstream and infiltrate pores in rapidly growing tumor blood ves
FILE - This Aug. 10, 2009 file photo shows research nurse Wendy Nesheim drawing H1N1 flu vaccine into a syringe to administer to volunteer participants during first of several clinical trials conducted by Emory University in Atlanta. A White House report from an expert panel suggests that from 30 pe
Dr. Lisa Jackson, a researcher with Group Health Center for Health Studies, who is a chief investigator for the H1N1 clinical trials, participates in a Swine Flu conference call at her Seattle office on July 27.